Novartis buys antibiotics business from GSK in generics push

ZURICH (Reuters) - Swiss drugmaker Novartis' generics division is buying a GlaxoSmithKline antibiotics business that includes the brands Zinnat, Zinacef and Fortum for up to $500 million, the drugmakers said on Thursday.

Reuters February 12, 2021 00:05:44 IST
Novartis buys antibiotics business from GSK in generics push

Novartis buys antibiotics business from GSK in generics push

ZURICH (Reuters) - Swiss drugmaker Novartis' generics division is buying a GlaxoSmithKline antibiotics business that includes the brands Zinnat, Zinacef and Fortum for up to $500 million, the drugmakers said on Thursday.

Novartis' Sandoz unit will pay GSK $350 million for the cephalosporin antibiotics business at the closing of the deal, which is expected in the second half of this year, plus a further $150 million upon hitting set milestones.

Britain's GSK is splitting itself into two companies - one focusing on over-the-counter products and the other on prescription drugs and vaccines, seeking a leaner structure as it invests in newer medicines.

The cephalosporin class of antibiotics is widely used to treat various bacterial infections. The three brands that are part of Thursday's deal had combined sales of roughly $140 million in "relevant" markets last year and are now out of patent protection, GSK said. (https://bit.ly/3aXoa8O]

Under the deal, Sandoz will be able to sell the brands in all markets except Australia, China, Egypt, Germany, India, Japan, Pakistan, and the United States, GSK said.

Other GSK antibiotic brands are not part of the sale to Sandoz, according the British company, which said it would also close its cephalosporins manufacturing operations once it has finished transferring production to Sandoz, expected in 2025.

Although GSK did not announce any job cuts related to the deal, it said all 170 roles in the Zinnat supply chain would be affected, adding that it would provide support to the employees. It did not provide further details.

(Reporting by Michael Shields in Zurich, and Pushkala Aripaka and Muvija M in Bengaluru; Editing by John Revill and Pravin Char)

This story has not been edited by Firstpost staff and is generated by auto-feed.

Updated Date:

TAGS:

Subscribe to Moneycontrol Pro at ₹499 for the first year. Use code PRO499. Limited period offer. *T&C apply

also read

Thyssenkrupp ends talks with UK's Liberty on steel unit sale
Business

Thyssenkrupp ends talks with UK's Liberty on steel unit sale

By Christoph Steitz, Tom Käckenhoff and Arno Schuetze FRANKFURT (Reuters) - German conglomerate Thyssenkrupp ended talks to sell its steel division to Britain's Liberty Steel due to differences over value, the latest setback in efforts to consolidate the European sector. Liberty Steel, led by commodities tycoon Sanjeev Gupta, last month submitted a firmed-up non-binding bid for Thyssenkrupp's steel unit, Europe's second biggest in terms of sales, which sources said included commitments to protect jobs and sites.

Factbox: Stonks in Washington: Deciphering Reddit's WallStreetBets lingo
Business

Factbox: Stonks in Washington: Deciphering Reddit's WallStreetBets lingo

(Reuters) - Reddit trading lingo may filter in to Washington on Thursday when top hedge fund managers, the head of Robinhood and Roaring Kitty himself are set to give testimony before U.S. House of Representatives lawmakers.

Brent gives up gains after rising above $65 on Texas freeze
Business

Brent gives up gains after rising above $65 on Texas freeze

By Stephanie Kelly NEW YORK (Reuters) - Oil prices steadied on Thursday, with Brent edging back from a 13-month high, after a sharp drop in U.S. crude inventories supported prices, while buying spurred by a cold snap in the largest U.S. energy-producing state petered out.